Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2003

View Archived Issues

Roxifiban does not activate platelets from healthy volunteers

Pozen submits MT-100 NDA

Medivir licenses MIV-150 to Population Council

Kyorin and Eisai amend Maxalt agreement

MOR-201 program discontinued in Q2 at MorphoSys

Oxagen identifies novel diabetes gene

FDA approval for Rebetol in pediatric hepatitis C

Probactrix controls HIV-associated diarrhea in clinical trial

Health Canada grants clearance for initiation of phase II studies of Infecton

Pfizer returns P-57 rights to Phytopharm

Strategic review and Q2 results at Shire

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Use of amylin agonists for reducing triglyceride levels

Adenosine receptor ligands and their use in depression and other disorders

IGF-I peptides useful in ophthalmology and dermatology

Bristol-Myers Squibb presents new antiviral compounds

New nuclear hormone receptor modulators synthesized at BMS

Camptothecin encapsulated in cationic liposomes targets tumor blood vessels

LipoRed: a cationic liposome-based neovascular imaging agent

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Prous Science announces the addition of Chronic Rhinosinusitis to the Drug R&D Backgrounders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...